FLT3-Mutated AML: Biology and Treatment – Resonance

FLT3-Mutated AML: Biology and Treatment – Resonance

ALRCaN presents “FLT3-Mutated AML: Biology and Treatment” with Dr. Mark J. Levis.

“Dear friends and colleagues,

We look forward to seeing you every Friday at 9 am ET to enjoy lively discussion of leukemia and supportive care topics.

Warm regards,

Scott Howard, Stacy Cooper, Archie Bleyer, Dan Douer, and Resonance Team.”

Date: July 31, 2026
Time: 09:00 AM–10:00 AM ET (05:00 PM–06:00 PM AMT)
Presenter: Mark J. Levis
Organizer: ALRCaN Global/Resonance Health

You can read more posts featuring Resonance on OncoDaily.